XOMAP
XOMA Corporation
NASDAQ · Healthcare · Biotechnology · US
$24.98
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.14x
- PEG TTM
- 1.14x
- Price / book
- 0.22x
- Price / sales
- 0.90x
- Price / cash flow
- 3.71x
Enterprise value
- Enterprise value
- $74.4M
- EV / sales
- 2.72x
- EV / EBITDA
- 1.47x
- EV / EBIT
- 14.96x
- Market cap
- $24.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026